NovoCure Limited has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission to raise up to $300 million in an initial public offering of common shares.
The company did not specify the number of shares to be sold and the pricing.
The company said it has applied...
DelMar Pharmaceuticals Inc. (DMPI.OB) will host a business update conference call at 11:00 AM ET on September 4, 2015.
To access the live webcast, log on to http://ir.delmarpharma.com/ir-calendar
To listen to the call, dial (866) 394-9399 with Conference ID 22042321.